• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

AI Shows High Accuracy in Suicide Risk Assessment: NeuroFlow Study

by Fred Pennic 04/29/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– NeuroFlow, a company focused on uncovering hidden behavioral health needs to enable more effective care, today published new research findings demonstrating how technology can significantly improve the ability to identify suicide risk, often among individuals who might otherwise go undiagnosed.

–  The studies highlight the potential for user-friendly digital tools and artificial intelligence (AI) to assess risk more efficiently, detect suicidal ideation sooner, and ultimately facilitate life-saving interventions.

The Urgent Need for Better Suicide Prevention Tools

Suicide remains a critical public health crisis in the United States, with over 1.5 million people attempting suicide annually and approximately 49,000 lives lost each year. These staggering numbers, which continue to rise, carry devastating personal and societal impacts, contributing billions to healthcare costs. NeuroFlow emphasizes that effective prevention requires innovative approaches, as many individuals at risk are “hiding in plain sight.” Troublingly, over half of those who die by suicide have had contact with the healthcare system within 30 days prior to their death, indicating missed opportunities for intervention. Technology offers a path to identify these individuals sooner.

Study 1: Everyday Digital Tracking Predicts Suicidal Ideation Risk

The first study, published in the Journal of Technology in Behavioral Science (JTIBS) and titled “Predicting Risk of Suicidal Ideation with Digital Ecological Momentary Assessment (EMA),” analyzed data from over 30,000 individuals using NeuroFlow’s digital platform. Users tracked daily metrics like mood, stress, sleep, and pain – tasks taking only a few seconds. The research found that these simple, self-reported measures accurately predicted the risk of suicidal ideation, with mood emerging as a particularly strong indicator. While validated clinical assessments like the PHQ-9 remain the “gold standard” for intake, the study observed a clear patient preference for brief trackers, completed 18 times more often than clinical assessments.

“We’re encouraged about the potential of mood scoring and stress tracking – directly correlating with suicidal ideation – as a way to fuel our risk stratification model,” said NeuroFlow Chief Medical Officer Tom Zaubler, MD. “This is a new and legitimate input for preventing suicide, and it reflects NeuroFlow’s expertise in gathering disparate data to make sense of often hidden or complex behavioral health conditions. We’ve always known patients enjoy using trackers to monitor their own progress, and we’re excited to connect this high-volume activity to identifying actual risk.”

Study 2: AI Demonstrates High Accuracy in Assessing Risk from Journaling

A second study, currently under review at BMC Psychiatry and titled “Evaluating Generative Pretrained Transformer (GPT) Models for Suicide Risk Assessment in Synthetic Patient Journal Entries,” explored the use of AI in risk detection. Using a dataset of clinically validated synthetic patient journal entries to ensure safety and privacy, researchers compared risk ratings generated by large language models (LLMs) against assessments made by five independent clinical experts. The findings were compelling: NeuroFlow’s ensemble AI model agreed with the experts’ intervention decisions 92% of the time, demonstrating AI’s potential as a fast, accurate, and scalable tool for identifying risk within patient narratives.

“Artificial intelligence is one of the most democratizing tools of our generation. It has the potential to add a layer of patient insight across the healthcare system – instead of siloing behavioral health data to one site of care,” stated NeuroFlow researcher Dan Holley, PhD. “What we’ve been able to prove is that AI is capable of augmenting care teams by triaging thousands of patient records to rapidly turn risk indicators into actionable health intelligence, potentially enabling lifesaving interventions.”

Taken together, these studies underscore how combining readily available self-reported data (like mood tracking) with AI-driven analysis can significantly enhance suicide prevention efforts.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |